2Q figures from ContextVision came in weaker due to COVID-19. Still, long-term prospects are highly interesting, but share remains rather fairly priced. We will revise our estimates, TP and recommendation following the report, but unless there is a more significant correction in the stock price, our Hold recommendation is likely to stay.
(Norne)